Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

234
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
234
Clinical Trials01:16

Clinical Trials

6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous Intraperitoneal Insulin Infusion for People With Type 1 Diabetes: A Literature Review and International Position Statement.

Diabetes, obesity & metabolism·2026
Same author

A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent-Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design.

Diabetes, obesity & metabolism·2026
Same author

Mitigating Glycemic Disparities: Understanding Contributions of Sociodemographic Variables in the Teamwork, Targets, Technology, and Tight Glycemia (4T) Study.

The Journal of pediatrics·2026
Same author

Micro-randomization trial design under operational constraints.

Contemporary clinical trials·2026
Same author

Poor Glycemic Status Is Associated With Diabetes Distress After Total Pancreatectomy With Islet Autotransplantation.

Clinical transplantation·2026
Same author

Advancing Early-Stage Type 1 Diabetes Care: Future Focused Pathways for Identification, Screening, Diagnosis, and Monitoring.

Diabetes, obesity & metabolism·2026

Related Experiment Video

Updated: Jun 4, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.2K

Project ECHO Diabetes Trial Improves Outcomes for Medically Underserved People.

Ashby F Walker1,2, Michael J Haller1,3, Ananta Addala4,5

  • 1University of Florida Diabetes Institute, Gainesville, FL.

Diabetes Care
|December 17, 2024
PubMed
Summary

The Project Extension for Community Healthcare Outcomes (ECHO) model improved diabetes care by reducing HbA1c levels and increasing technology use in federally qualified health centers. This tele-education approach shows promise in reducing health disparities.

More Related Videos

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

2.8K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

Related Experiment Videos

Last Updated: Jun 4, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.2K
Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

2.8K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

Area of Science:

  • Health Services Research
  • Telemedicine
  • Diabetes Management

Background:

  • The Project Extension for Community Healthcare Outcomes (ECHO) model utilizes a tele-education approach to empower providers in managing chronic diseases.
  • Few studies have rigorously evaluated the ECHO model's impact on patient outcomes using randomized designs, particularly in diabetes care.

Purpose of the Study:

  • To evaluate the impact of the ECHO Diabetes program on patient outcomes and technology use in federally qualified health centers (FQHCs).
  • To assess the effectiveness of a stepped-wedge randomized design in evaluating a large-scale tele-education program.

Main Methods:

  • A stepped-wedge design was employed, involving 20 FQHCs across California and Florida with phased intervention entry.
  • Data collected included Healthcare Effectiveness Data and Information Set (HEDIS) measures, diabetes technology use, HbA1c levels, and patient surveys.
  • Linear mixed models and Poisson regression were used to analyze patient-level HbA1c and clinic-level technology adoption.

Main Results:

  • A statistically significant reduction in the proportion of patients with HbA1c >9% was observed post-intervention (31.7% to 26.7%, P = 0.033).
  • Significant increases in continuous glucose monitoring (25.1% to 36.8%, P < 0.0001) and insulin pump use (15.3% to 18.3%, P < 0.001) were noted at the patient level.
  • The study included a large spoke-level cohort (32,796 patients) and a patient-level cohort (582 adults), with a majority being publicly insured or uninsured.

Conclusions:

  • The ECHO Diabetes program demonstrates significant promise in improving diabetes care and reducing health disparities.
  • The findings support the ECHO model's effectiveness beyond provider education, impacting patient health outcomes and technology adoption.